CSPG5
Basic information
Region (hg38): 3:47562238-47580792
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CSPG5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 38 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 1 | 1 |
Variants in CSPG5
This is a list of pathogenic ClinVar variants found in the CSPG5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-47562647-C-T | not specified | Uncertain significance (May 01, 2024) | ||
3-47562688-A-T | not specified | Uncertain significance (Jun 27, 2022) | ||
3-47569090-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
3-47569106-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
3-47569114-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
3-47569126-C-A | not specified | Uncertain significance (Nov 18, 2023) | ||
3-47569180-G-C | not specified | Uncertain significance (Jun 27, 2023) | ||
3-47569220-G-A | not specified | Uncertain significance (Feb 06, 2024) | ||
3-47572695-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
3-47572696-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
3-47572749-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
3-47572774-C-T | not specified | Uncertain significance (Oct 19, 2024) | ||
3-47572836-C-T | not specified | Uncertain significance (May 05, 2023) | ||
3-47572863-T-G | not specified | Uncertain significance (Apr 07, 2022) | ||
3-47572866-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
3-47576888-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
3-47576947-C-A | not specified | Uncertain significance (Apr 17, 2024) | ||
3-47576996-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
3-47577071-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
3-47577082-T-C | not specified | Uncertain significance (Nov 18, 2023) | ||
3-47577101-G-C | not specified | Uncertain significance (May 26, 2022) | ||
3-47577103-C-T | not specified | Uncertain significance (Mar 16, 2024) | ||
3-47577189-C-G | not specified | Uncertain significance (Jan 26, 2022) | ||
3-47577263-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
3-47577294-C-G | not specified | Uncertain significance (Feb 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CSPG5 | protein_coding | protein_coding | ENST00000383738 | 5 | 18554 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0562 | 0.940 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.34 | 251 | 318 | 0.788 | 0.0000180 | 3637 |
Missense in Polyphen | 87 | 139.05 | 0.62565 | 1546 | ||
Synonymous | 1.04 | 124 | 140 | 0.888 | 0.00000883 | 1193 |
Loss of Function | 2.56 | 5 | 16.1 | 0.311 | 6.84e-7 | 209 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000591 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000268 | 0.0000264 |
Middle Eastern | 0.0000591 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a growth and differentiation factor involved in neuritogenesis. May induce ERBB3 activation. {ECO:0000269|PubMed:15358134}.;
- Pathway
- Metabolism of carbohydrates;A tetrasaccharide linker sequence is required for GAG synthesis;Heparan sulfate/heparin (HS-GAG) metabolism;Chondroitin sulfate biosynthesis;Dermatan sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.368
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.45
Haploinsufficiency Scores
- pHI
- 0.472
- hipred
- Y
- hipred_score
- 0.622
- ghis
- 0.500
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.406
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cspg5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- nervous system development;regulation of signaling receptor activity;cell differentiation;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;regulation of growth;intracellular transport;trans-synaptic signaling, modulating synaptic transmission;regulation of synaptic vesicle exocytosis
- Cellular component
- Golgi membrane;extracellular region;endoplasmic reticulum membrane;Golgi apparatus;Golgi lumen;integral component of plasma membrane;cell surface;membrane;integral component of membrane;Golgi-associated vesicle membrane;lysosomal lumen;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic membrane
- Molecular function
- protein binding;growth factor activity